Discovery series: Is it time to start looking at this quality diagnostic service?

We expect an earnings CAGR in mid-teens in the medium term for VDC on the back of an expansion-led volume growth in the hinterland

Anubhav Sahu
October 04, 2022 / 04:28 PM IST
Discovery series: Is it time to start looking at this quality diagnostic service?

Representative image

PRO Only Highlights
-  Quarterly performance largely backed by improved realisations
-  Medium-term triggers China plus and protectionist measures for tyre industry
-  Valuations not inexpensive; but improved medium-term outlook

Highlights Pricing threat may not be sustainable; service focus would be key differentiator Vijay Diagnostics - a play on regional healthcare needs Differentiated business model with broad range of offerings The stocks of most of diagnostic service companies have dropped more than 50 percent from their 52-week highs. Though the key reason is the COVID revenue cliff, even more crucial is the entry of new diagnostic service providers. These include some of the known names in the pharma industry such as Lupin, Mankind...